Identification of factors related to immunotherapy prognosis in patients with advanced head and neck squamous cell carcinoma.

e18003Background: Head and neck squamous cell carcinoma (HNSCC) is often diagnosed at an advanced stage and has a dismal prognosis. Anti-PD1/PD-L1 checkpoint inhibitors have shown survival benefit ...